14:30 27/05/2016 Arena Pharmaceuticals Incorporated (NASDAQ:ARNA) Sellers Covered 4.61% of ...
Arena Pharmaceuticals Incorporated (NASDAQ:ARNA) Sellers Covered 4.61% of ...
Franklin Independent - 10 hours ago
The ratio is negative, as 21 funds sold all Arena Pharmaceuticals, Inc. shares owned while 37 reduced positions. 14 funds bought stakes while 31 increased positions.

14:07 27/05/2016 Best Stocks: Liberty Global plc (NASDAQ:LBTYK), Arena Pharmaceuticals, Inc ...
Best Stocks: Liberty Global plc (NASDAQ:LBTYK), Arena Pharmaceuticals, Inc ...
Benchmark Monitor - 10 hours ago
On 16 May, Liberty Global plc (NASDAQ: LBTYK) announced that it has completed its acquisition of Cable & Wireless Communications Plc (“CWC”) in a transaction valued at approximately $7.4 billion3 on an enterprise value basis.

20:30 26/05/2016 Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Quarterly EPS From Continuing ...
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Quarterly EPS From Continuing ...
Enterprise Leader - May 26, 2016
For the year ended 2016-03-31 Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) basic consolidated EPS reported was $-0.4487.
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) - Broker Update - Risers & Fallers
Which way Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) earnings may go - iStreetWire

13:56 26/05/2016 Active Biotech Stock News: ZIOPHARM Oncology (ZIOP), Arena Pharmaceuticals (ARNA)
Active Biotech Stock News: ZIOPHARM Oncology (ZIOP), Arena Pharmaceuticals (ARNA)
Zergwatch - May 26, 2016
ZIOPHARM Oncology, Inc. (ZIOP) ended last trading session with a change of 1.14 percent. It trades at an average volume of 2.64M shares versus 2.03M shares recorded at the end of last trading session.

13:45 26/05/2016 Analyst ratings Updates: Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX ...
Analyst ratings Updates: Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX ...
WsNews 4investors - May 26, 2016
Shares of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) declined -2.45% and ended at $1.59 smaller than previous closing price of $1.63.

17:30 23/05/2016 Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Analyst Research Summary:
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Analyst Research Summary:
CWRU Observer - May 23, 2016
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) stock is currently trading at about $1.57 and lots of rating firms seem to have a target price set on the stock.
Broker Changes For Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) - Risers & Fallers
Arena Pharmaceuticals Incorporated (NASDAQ:ARNA) Short Interest Decreased By 5.03% - Franklin Independent

14:18 19/05/2016 Analysts: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Stock Could Go to $4.00
Analysts: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Stock Could Go to $4.00
CWRU Observer - May 19, 2016
Analysts are weighing in on how Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) , might perform in the near term. Wall Street analysts have a much less favorable assessment of the stock, with a mean rating of 2.7.
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Stock Declines, Analysts: Hold Rating - Street Register

16:33 17/05/2016 Biotech Stocks Worth Chasing: ACADIA Pharmaceuticals Inc. (ACAD), Arena ...
Biotech Stocks Worth Chasing: ACADIA Pharmaceuticals Inc. (ACAD), Arena ...
Zergwatch - May 17, 2016
ACADIA Pharmaceuticals Inc. (ACAD) ended last trading session with a change of 6.83 percent. It trades at an average volume of 3.23M shares versus 2.54M shares recorded at the end of last trading session.

12:14 12/05/2016 2 Sizzling Hot Biotechnology Stocks: Arena Pharmaceuticals, Inc. (ARNA ...
2 Sizzling Hot Biotechnology Stocks: Arena Pharmaceuticals, Inc. (ARNA ...
Zergwatch - May 12, 2016
Arena Pharmaceuticals, Inc. (ARNA) ended last trading session with a change of -3.73 percent. It trades at an average volume of 1.96M shares versus 2.5M shares recorded at the end of last trading session.
Upgrades And Downgrades For Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) - Risers & Fallers
Market Analyst Recent Rating Update: AbbVie Inc. (NYSE:ABBV), Arena ... - WsNews 4investors

13:11 09/05/2016 Stock Earnings Estimates under Discussion: Arena Pharmaceuticals, Inc. (NASDAQ ...
Stock Earnings Estimates under Discussion: Arena Pharmaceuticals, Inc. (NASDAQ ...
The Point Review - May 9, 2016
Wall Street analysts are predicting that Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) will report earnings per share of $-0.10 in their quarterly report.
Arena Pharmaceuticals Announces Appointment of Amit D. Munshi as President and ... - PR Newswire (press release)